HOME Top Market Reports U.S. Cervical Cancer Screening Market by Test Type (PAP, HPV), Kit Type (PAP, HPV), End User (Hospitals, Laboratories, Physicians’ Offices & Clinics) - Global Forecast to 2020

U.S. Cervical Cancer Screening Market by Test Type (PAP, HPV), Kit Type (PAP, HPV), End User (Hospitals, Laboratories, Physicians’ Offices & Clinics) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: January 2018
Report Code: UC 1710

Discount on Prebooks  

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global cervical cancer screening market was approximately $15 billion in 2014 and is estimated to grow at a CAGR of 7.0% to reach nearly $22 billion by 2020. PAP test is the largest segment of the global market. However, HPV/co-test will be the fastest-growing product segment during the forecast period.

This report segments the global cervical cancer screening  market by test, and end user. Based on type of test, the global market is segmented into PAP test, and HPV test/co-testing.

On the basis of end users, the global cervical cancer diagnosis market is categorized into hospitals, laboratories, and physician’s offices and clinics. Laboratories segment is the major end users of the global market in 2014.  Based on geography, the global market is broadly divided into North America, Europe, Asia-Pacific, and RoW.

Growth of this market is driven by growth in aging female population and rising prevalence rate of cervical cancer, high incidence rate of HPV infections, increasing number of awareness programs for cervical cancer diagnostic, and government initiatives and funding. Breakthrough products and technologies, and significant growth in the HPV test market provide new growth opportunities to players in the global market. However, Changes in regulatory guidelines for cervical cancer screening, and use of HPV vaccines are the key factors that are limiting growth of this market.  In addition, uncertain reimbursement scenario is the key market challenges.

Some of the major players operating in the global cervical cancer screening market are Hologic Corporation, Becton, Dickinson and Company, Qiagen N.V., and Hoffmann-La Roche.

Scope of the Report

The volume market is not covered in this market report.


Particular

Scope

Geography

  • North America (U.S. and Canada)
  • Europe
  • Asia-Pacific
  • RoW

Historical Years

2012-2013

Base Year

2014

Projected Year

2015-2020

Revenue Currency

USD ($)

Market Segmentation

This research report categorizes the global cervical cancer screening market on the basis of type of test, and end users.

Cervical Cancer Screening Market, by Test

  • Pap tests
  • HPV test/ Co-testing

Cervical Cancer Screening Market, y End User

  • Hospitals
  • Laboratories
  • Physician’s offices and clinics

Cervical Cancer Screening Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • RoW (Rest of the World)

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Markets Covered
    1.3 Stakeholders
    1.4 Market Scope

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Crackdown & Data Triangulation
    2.3 Market Share Estimation
           2.3.1  Key Data Points From Secondary Sources
           2.3.2  Key Data Points From Primary Sources
                     2.3.2.1  Key Industry Insights
           2.3.3  Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
    5.4 Winning Imperatives
    5.5 Burning Issues

6 Industry Insights
    6.1 Introduction
    6.2 Supply Chain Analysis
           6.2.1  Key Influencers
    6.3 Industry Insights
    6.4 Strategic Benchmarking
    6.5 Cervical Cancer Incidence Rates
    6.6 Regulatory Guidelines and Reimbursement Scenario
    6.7 Pricing Analysis

7 Cervical Cancer Screening Market, by Test Type
    7.1 Introduction
    7.2 PAP Tests
    7.3 HPV Tests

8 Cervical Cancer Screening Market, by End Users
    8.1 Introduction
    8.2 Hospitals
    8.3 Laboratories
    8.4 Physicians’ Offices & Clinics

9 Geographic Analysis
    9.1 North America
           9.1.1  U.S.
           9.1.1  Canada
    9.2 Europe
           9.2.1  Germany
           9.2.2  U.K.
           9.2.3  Rest of Europe (ROE)
    9.3 Asia-Pacific
           9.3.1  India
           9.3.2  China
           9.3.3  Japan
           9.3.4  Rest of Asia Pacific (ROAPAC)
     10.4 Rest of the World (ROW)

10 Competitive Landscape
     10.1 Introduction
     10.2 Mergers & Acquisitions
     10.3 Agreements, Partnerships, Collaborations, Joint Ventures
     10.4 New Product Launch
     10.5 Approvals
     10.6 Expansion
     10.7 Others

11 Company Profiles*

*(Overview, Financials, Products & Services, Strategy, & Developments)*
     11.1 Introduction
     11.2 Hologic, Inc.
     11.3 Qiagen N.V.  
     11.4 Roche Diagnostics  
     11.5 Quest Diagnostics  
     11.6 Oncohealth Corporation  
     11.7 Femasys, Inc.  

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Introducing Rt: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports


List of Tables (61 Tables)

Table 1 Cervical Cancer Screening Market Size, By Test Type, 2014 ($Million)
Table 2 Tests Market Size, By Test Type, 2020 ($Million)
Table 3 List of FDA-Approved Products for PAP Tests
Table 4 List of FDA-Approved Products for HPV Tests
Table 5 No. of New Cancer Cases, By Type, 2014
Table 6 Regulatory Landscape Analysis, By Country
Table 7 Percentage Share of Cervical Cancer Cases, By Age Group, 2014
Table 8 Percentage of PAP Test Screening, By Age Group
Table 9 Penetration Rate of Tests, By Type, 2014 Vs. 2020 (%)
Table 10 No. of Cervical Cancer Diagnosis Market, By Test Type, 2012–2020 (Million)
Table 11 No. of PAP Smear Tests, 2012–2020 (Million)
Table 12 No. of HPV Tests, 2012–2020 (Million)
Table 13 North America: Market Size, By Test Type, 2012–2020 ($Million))
Table 14 North America: Cervical Cancer Tests Market Share, By Test Type, 2012-2020 ($Million)
Table 15 North America: Pricing Trend Analysis, PAP and HPV Tests, 2012–2020
Table 16 North America: Cervical Cancer Diagnosis Kits Market Size, By Test Type, 2012–2020 ($Million)
Table 17 North America: Cervical Cancer Kits Market Share, By Test Type, 2012–2020 ($Million)
Table 18 North America: Cervical Cancer Kits Market Size, By End User, 2012–2020 ($Million)
Table 19 North America: Cervical Cancer Screening Market Size, By End User, 2012–2019 ($Million)
Table 20 U.S. : Market Size, By Test Type, 2012–2020 ($Million))
Table 21 U.S. : Cervical Cancer Tests Market Share, By Test Type, 2012-2020 ($Million)
Table 22 U.S. : Pricing Trend Analysis, PAP and HPV Tests, 2012–2020
Table 23 U.S. : Cervical Cancer Diagnosis Kits Market Size, By Test Type, 2012–2020 ($Million)
Table 24 U.S. : Cervical Cancer Kits Market Share, By Test Type, 2012–2020 ($Million)
Table 25 U.S. : Cervical Cancer Kits Market Size, By End User, 2012–2020 ($Million)
Table 26 U.S. : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 27 Canada : Cervical Cancer Screening Market Size, By Test Type, 2012–2020 ($Million))
Table 28 Canada : Cervical Cancer Tests Market Share, By Test Type, 2012-2020 ($Million)
Table 29 Canada : Pricing Trend Analysis, PAP and HPV Tests, 2012–2020
Table 30 Canada : Cervical Cancer Diagnosis Kits Market Size, By Test Type, 2012–2020 ($Million)
Table 31 Canada : Cervical Cancer Kits Market Share, By Test Type, 2012–2020 ($Million)
Table 32 Canada : Cervical Cancer Kits Market Size, By End User, 2012–2020 ($Million)
Table 33 Canada : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 34 Europe : Cervical Cancer Screening Market Size, By Test Type, 2012–2020 ($Million))
Table 35 Europe : Pricing Trend Analysis, PAP and HPV Tests, 2012–2020
Table 36 Europe : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 37 Germany : Cervical Cancer Screening Market Size, By Test Type, 2012–2020 ($Million))
Table 38 Germany : Pricing Trend Analysis, PAP and HPV Tests, 2012–2020
Table 39 Germany : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 40 U.K. : Market Size, By Test Type, 2012–2020 ($Million))
Table 41 U.K.  : Pricing Trend Analysis, PAP and HPV Tests, 2012–2020
Table 42 U.K.  Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 43 ROE : Market Size, By Test Type, 2012–2020 ($Million))
Table 44 ROE : Pricing Trend Analysis, PAP and HPV Tests, 2012–2020
Table 45 ROE : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 46 Asia-Pacific : Market Size, By Test Type, 2012–2020 ($Million))
Table 47 Asia-Pacific : Pricing Trend Analysis, PAP and HPV Tests, 2012–2020
Table 48 Asia-Pacific : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 49 India : Market Size, By Test Type, 2012–2020 ($Million))
Table 50 India : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 51 China : Market Size, By Test Type, 2012–2020 ($Million))
Table 52 China : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 53 Japan : Market Size, By Test Type, 2012–2020 ($Million))
Table 54 Japan : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 55 ROW :  Market Size, By Test Type, 2012–2020 ($Million))
Table 56 ROW : Pricing Trend Analysis, PAP and HPV Tests, 2012–2020
Table 57 ROW : Cervical Cancer Tests Market Size, By End User, 2012–2019 ($Million)
Table 58 New Product Launches, 2012–2015
Table 59 Agreements, Partnerships, and Collaborations, 2012–2015
Table 60 Expansions, 2012–2015
Table 61 Other Developments, 2012–2015
 
 
List of Figures (24 Figures)
 
Figure 1 Research Methodology
Figure 2 Market Size Estimation
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Data Triangulation Methodology
Figure 5 Tests Market Size, 2014 Vs. 2019 ($Million)
Figure 6 No. of Cervical Cancer Tests, 2014 Vs. 2019 (Million)
Figure 7 Geographical Snapshot: North America Dominated the Cervical Cancer Screening Market in 2014
Figure 8 New Product Launch is the Major Growth Strategy Adopted By the Players in this Market
Figure 9 Market Share, By Test Type, 2014 ($Million)
Figure 10 Cervical Cancer Diagnosis Kits Market Share, By Test Type, 2014 ($Million)
Figure 11 Cervical Cancer Kits Market Share, By End User, 2014 Vs. 2019 ($Million)
Figure 12 Cervical Cancer Tests Market Share, By End User, 2014 Vs. 2019 ($Million)
Figure 13 Global Cervical Cancer Diagnosis Kits Market Share Analysis, By Key Player, 2014 Vs. 2019
Figure 14 Companies Adopted New Product Launches as A Key Growth Strategy From 2012 to 2015
Figure 15 Hologic, Inc. : Company Snapshot
Figure 16 Qiagen N.V.  : Company Snapshot
Figure 17 Roche Diagnostics : Company Snapshot
Figure 18 Quest Diagnostics : Company Snapshot
Figure 19 Oncohealth Corporation : Company Snapshot
Figure 20 Femasys, Inc. : Company Snapshot
Figure 21 Neusoft Medical Systems Co. Ltd.: Company Snapshot
Figure 22 Philips Healthcare: Company Snapshot
Figure 23 Siemens Healthcare: Company Snapshot
Figure 24 Toshiba Medical Systems Corporation: Company Snapshot

The global cervical cancer screening market is expected to grow at a single–digit CAGR of 7.0% to reach $22 billion by 2020 from ~$15 million in 2014. Major factors fueling growth of this market are, growth in aging female population and rising prevalence rate of cervical cancer, high incidence rate of HPV infection, increasing number of awareness programs for cervical cancer screening, and government initiatives and funding. However Changes in regulatory guidelines for cervical cancer diagnostic, and use of HPV vaccines are restricting the growth of this market.

The global cervical cancer screening market is broadly segmented into major two segments on basis of type of test, namely, Pap test, and HPV test/ Co-testing. On the basis of end users, the global market is categorized into hospitals, laboratories, and physician’s offices and clinics. Laboratories segment was the major end users of the global market in 2014.

Geographically, the global market is broadly divided into North America, Europe, Asia-Pacific, and RoW. Some of the major players operating in the global market are Hologic Corporation, Becton, Dickinson and Company, Qiagen N.V., and Hoffmann-La Roche.

Global Cervical Cancer Screening Market Scenario, by Test Type, 2014

Cervical Cancer Screening Market

Global Cervical Cancer Screening Market Scenario, by End User, 2014

Cervical Cancer Screening Market

Available Customizations Title

Client Consult Problem Statement : MnM’s client, a leading medical device and diagnostics company, was losing its market share in the cervical cancer test kits market in U.S. and wanted to understand the dynamics of these kits in U.S. in terms of value and volume (number of tests and kits sold per year). The project focused on segments by test kits (Pap and HPV) and End-users (Hospitals, Laboratories, Physicians). The project also aimed at estimating the number of Pap tests and HPV tests and analyzing their trends.

Solution Provided:

1. Methodology Adopted by MnM :

Both, top-down and bottom-up approaches were us....

1. Methodology Adopted by MnM :

Both, top-down and bottom-up approaches were used to derive the data. MnM utilized authentic secondary sources (government websites, associations and groups, annual reports of companies, SEC filings, corporate presentations) along with MnM Repository to gain insights, both quantitative and qualitative, into the market. MnM then conducted multi-level, qualitative & quantitative study with a constructed sample of mid to senior level management executives and industry professionals to understand key parameters influencing the market. At every level the estimates were further verified with industry experts.

2. Actual Solution Provided:

   • Market sizing and forecast for cervical cancer screening test kits and procedures
   • Guidelines for regulations associated with cervical cancer in U.S.
   • Profile of key companies and competitive landscape
   • Strategic insights for market penetration and positioning

Value Delivered:

The client could identify the market potential and challenges in the market. They were also able to identify the reasons for dropping sales which aided them to take appropriate steps to improve their sales.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo